ArticleRheumatology and therapy2025

Response to Tofacitinib in Patients with Psoriatic Arthritis and Probable Anxiety/Depressive Disorder: A Post Hoc Analysis of Phase 3 Trials.

Laure Gossec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.